Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$238,281
New position
Shares Held
21,525
first reported quarter
Ownership
0.023%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#103
of 198 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026IRONWOOD INVESTMENT MANAGEMENT LLC holds $13,113,875 across 6 Biotechnology names. REPL ranks #5 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
56,589 | $4,820,816 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
61,163 | $4,555,420 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
113,387 | $1,924,177 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
52,080 | $1,339,497 | |
| 5 | REPL |
Replimune Group, Inc.
This page
|
21,525 | $238,281 | |
| 6 | VALN |
Valneva SE
|
45,064 | $235,684 |
All Filings in REPL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,281 | 21,525 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||